Related Experiment Video
Updated: May 1, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.1K
Plumbagin analogs-synthesis, characterization, and antitubercular activity
Nishi Nayak1, Meenakshi Bajpai2, Balkishen Razdan3
1Pursuing Ph.D, Faculty of Pharmacy, Uttarakhand Technical University, Dehradun, India.
Journal of Advanced Pharmaceutical Technology & Research
|April 4, 2014
Summary
New Plumbagin analogs show potent activity against drug-resistant tuberculosis strains. These compounds offer a promising alternative to current therapies for multidrug-resistant tuberculosis (MDR-TB).
Area of Science:
- Medicinal Chemistry
- Microbiology
- Pharmacology
Background:
- Tuberculosis (TB) remains a critical global health issue, particularly in India, with rising drug resistance.
- Existing antitubercular therapies are ineffective against multidrug-resistant tuberculosis (MDR-TB).
- There is an urgent need for novel drug candidates to combat resistant TB strains.
Purpose of the Study:
- To synthesize new Plumbagin analogs from Plumbago zeylanica.
- To evaluate the in vitro antitubercular activity of synthesized Plumbagin analogs.
- To identify potent compounds effective against drug-sensitive and drug-resistant Mycobacterium tuberculosis strains.
Main Methods:
- Synthesis of Plumbagin analogs.
- Antitubercular activity evaluation using the Lowenstein-Jensen (LJ) medium or Resazurin Microplate Assay (REMA) method.
- Testing against standard H37Rv and multidrug-resistant Mycobacterium tuberculosis strains.
Main Results:
- Compound 'a' demonstrated significant antitubercular activity against both standard H37Rv and drug-sensitive Mycobacterium tuberculosis strains, outperforming Rifampicin.
- Other synthesized Plumbagin analogs also exhibited notable activity compared to Rifampicin.
- The study identified promising lead compounds for further development against resistant TB.
Conclusions:
- Plumbagin analogs represent a potential new class of drugs for treating drug-resistant tuberculosis.
- Further research is warranted to optimize these compounds for clinical application.
- These findings contribute to the development of urgently needed MDR-TB treatments.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
130
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
130
01:15Antifungal Agents
119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119
01:25Inhibitors of Bacterial Protein Synthesis
106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
01:15Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103
01:23Inhibitors of Gram-positive Cell Wall Synthesis
191
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191
01:27Production of Antibiotics
265
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
265